Siplizumab: A Deep Analysis into MEDI-507 and 288392-69-8 Siplizumab, previously recognized as MEDI-507 and bearing the substance designation 288392-69-8, represents a distinct antibody designed to precisely target the CD25 Siplizumab clinical molecule, a vital element of the IL-2 network. Its evolution focused on reducing T-cell expansion by disr